About Aesculapius
Aesculapius is a Healthcare company based in Brescia (Italy) founded in 1959, and was acquired by Ceres Pharma in January 2024. Pharmaceutical products, food supplements, and cosmetics are developed and sold. Its focus areas include Traditional Pharmaceuticals. Its legal entity is ÆSCULAPIUS Farmaceutici S.r.l.
Company details
Aesculapius was established in 1959 in Brescia, Italy, within the pharmaceutical sector. A variety of products is developed and distributed, encompassing medicines with original active ingredients and formulations, food supplements, cosmetics, and medical devices. Operations focus on innovation and compliance in the healthcare industry, serving markets through established supply chains in Europe.
- Headquarters Brescia, Italy
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website aesculapius.it
- Social LinkedIn Facebook
- Acquired by Ceres Pharma (Jan 2024)
- Legal Name Æsculapius Farmaceutici S.R.L.
- Investors
- Acquired byCeres Pharma
(Jan 2024)
Investors in Aesculapius
Aesculapius has secured backing from 1 investor. Prominent investors backing the company include Ceres Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Nutritional supplements are manufactured and marketed by Ceres Pharma. | 2017 | ceres-pharma.com | Merelbeke, Belgium |
Investor details for Aesculapius
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aesculapius
1 people are tracked at Aesculapius (1 in leadership).
| Name | Role | Group |
|---|---|---|
Enzo Moroni | Managing Director | Leadership |
Complete people profiles for Aesculapius
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Aesculapius
2 dated milestones of Aesculapius across 65 years, from founding to its latest funding, stage changes and deals.
- Founded Aesculapius is founded.
- Exit Acquired by Ceres Pharma.
Web traffic of Aesculapius
The website of Aesculapius (aesculapius.it) receives about 3.2K visits a month.
- Monthly visits3.2K
▲ 0.7% vs previous month
Websites whose visitors overlap most with Aesculapius. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
effeverde.it | effeverde.it | 100% | #752,788 | – | |
laboratorioasclepio.com | laboratorioasclepio.com | 100% | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aesculapius
Aesculapius was founded in 1959.
Aesculapius is headquartered in Brescia, Italy. It is registered at Brescia, Lombardy, Italy.
Aesculapius was established in 1959 in Brescia, Italy, within the pharmaceutical sector. A variety of products is developed and distributed, encompassing medicines with original active ingredients and formulations, food supplements, cosmetics, and medical devices. Operations focus on innovation and compliance in the healthcare industry, serving markets through established supply chains in Europe.
Aesculapius has 1 investor. Key investors include Ceres Pharma.
Aesculapius operates through Æsculapius Farmaceutici S.R.L..
Yes. Aesculapius was acquired by Ceres Pharma in January 2024.
